Showing 1 - 10 of 29,449
The efficient allocation of control rights in inter-firm collaborations is a widely emphasized issue. In this paper, I empirically identify control rights and the allocation of these rights using a unique survey data set on collaborations between biotechnology and pharmaceutical firms. Fifteen...
Persistent link: https://www.econbiz.de/10010383035
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, intending to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...
Persistent link: https://www.econbiz.de/10013405336
Persistent link: https://www.econbiz.de/10010518970
The biotechnology industry is one of the six emerging industries in Taiwan. Taking listed on the Taiwan Stock Exchange … (TSE) companies and over-the-counter (OTC) companies which form part of the biotechnology healthcare industry in Taiwan … value, while process capital and customer capital have a negative impact on the creation of enterprise value; and (3) Taiwan …
Persistent link: https://www.econbiz.de/10009785494
Persistent link: https://www.econbiz.de/10003715598
Persistent link: https://www.econbiz.de/10003641856
Persistent link: https://www.econbiz.de/10003760369
Persistent link: https://www.econbiz.de/10003898255
Persistent link: https://www.econbiz.de/10003456406
Persistent link: https://www.econbiz.de/10003300444